Allowing Access | GenomeWeb

Allowing Access

Biopharmaceutical firm AstaZeneca has announced that it is teaming up with researchers at the non-profit Medicines for Malaria Venture in an effort to "identify novel candidate drugs for the treatment of malaria." The MMV team "will screen 500,000 compounds in AstraZeneca's unique library for activity against P. falciparum, the most lethal of malaria parasites," according to the drug company's statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.